In vivo tracking of stem cells for clinical trials in cardiovascular disease

Circulation

Volumn 110, Issue 21, 2004, Pages 3378-3383

  Frangioni, John V ^a,c   Hajjar, Roger J ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Imaging; Radiology; Stem cells; Trials

Indexed keywords

8 QUINOLINOL INDIUM IN 111; CALCEIN; CONTRAST MEDIUM; FLUORINE 18; FLUOROCARBON; GADOLINIUM; GREEN FLUORESCENT PROTEIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; IODINE; IODINE 123; IODINE 124; LIPOSOME; LUCIFERASE; LUCIFERIN; SUPERPARAMAGNETIC IRON OXIDE; TECHNETIUM 99M; THYMIDINE KINASE; TRANSFERRIN I 125;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BIOLUMINESCENCE; CARDIOVASCULAR DISEASE; CELL SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL LASER MICROSCOPY; DOG; ECHOCARDIOGRAPHY; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; HEART FAILURE; HUMAN; HUMAN CELL; IMAGING; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; SWINE;

ANIMALS; CARDIOVASCULAR DISEASES; CELL SURVIVAL; CLINICAL TRIALS; CONTRAST MEDIA; FLUORESCENT DYES; GRAFT SURVIVAL; HUMANS; LUMINESCENT PROTEINS; MAGNETIC RESONANCE IMAGING; MICE; POSITRON-EMISSION TOMOGRAPHY; RATS; STEM CELL TRANSPLANTATION; STEM CELLS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 9344229796     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000149840.46523.FC     Document Type: Article

References (47)

1. Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003;108:2212-2218.
2. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415-419.
3. Klatzmann D, Valery CA, Bensimon G, et al. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther. 1998;9:2595-2604.
4. Wang X, Rosol M, Ge S, et al. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood. 2003;102:3478-3482.
5. Tang Y, Shah K, Messerli SM, et al. In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther. 2003;14:1247-1254.
6. Cao YA, Wagers AJ, Beilhack A, et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci USA. 2004;101:221-226.
7. Wu JC, Chen IY, Sundaresan G, et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation. 2003;108:1302-1305.
8. Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J Biomed Opt. 2001;6:432-440.
9. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol. 2003;7:626-634.
10. Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol. 2003;13:195-208.
11. Sevick-Muraca EM, Houston JP, Gurfinkel M. Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr Opin Chem Biol. 2002;6:642-650.
12. Reynolds JS, Troy TL, Mayer RH, et al. Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem Photobiol. 1999;70:87-94.
13. Nakayama A, del Monte F, Hajjar RJ, et al. Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Molecular Imaging. 2002;1:365-377.
14. Kim S, Lim YT, Soltesz EG, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol. 2004;22:93-97.
15. Zaheer A, Lenkinski RE, Mahmood A, et al. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol. 2001;19:1148-1154.
16. Nakayama A, Bianco AC, Zhang CY, et al. Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging. Molecular Imaging. 2003;2:37-49.
17. Klibanov AL, Rasche PT, Hughes MS, et al. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Invest Radiol. 2004;39:187-195.
18. Gao J, Dennis JE, Muzic RF, et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169:12-20.
19. Chin BB, Nakamoto Y, Bulte JW, et al. IIIIn oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun. 2003;24:1149-1154.
20. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108:863-868.
21. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation. 2003;107:2134-2139.
22. Gambhir SS, Herschman HR, Cherry SR, et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia. 2000;2:118-138.
23. Simonova M, Shtanko O, Sergeyev N, et al. Engineering of technetium-99m-binding artificial receptors for imaging gene expression. J Gene Med. 2003;5:1056-1066.
24. Bulte JW, Douglas T, Witwer B, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 2001;19:1141-1147.
25. Bulte JW, Douglas T, Witwer B, et al. Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents. Acad Radiol. 2002;9(suppl 2):S332-S335.
26. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage. 2002;17:803-811.
27. Josephson L, Tung CH, Moore A, et al. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem. 1999;10:186-191.
28. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410-414.
29. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 2003;228:760-767.
30. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology. 2003;228:480-487.
31. van den Bos EJ, Wagner A, Mahrholdt H, et al. Improved efficacy of stem cell labeling for magnetic resonance imaging studies by the use of cationic liposomes. Cell Transplant. 2003;12:743-756.
32. Garot J, Unterseeh T, Teiger E, et al. Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. J Am Coll Cardiol. 2003;41:1841-1846.
33. Hinds KA, Hill JM, Shapiro EM, et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood. 2003;102:867-872.
34. Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004;43:1315-1324.
35. Josephson L, Kircher MF, Mahmood U, et al. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem. 2002;13:554-560.
36. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;108:1009-1014.
37. Wickline SA, Lanza GM. Nanotechnology for molecular imaging and targeted therapy. Circulation. 2003;107:1092-1095.
38. Ford JW, Welling TH, 3rd, Stanley JC et al. PKH26 and 125I-PKH95: characterization and efficacy as labels for in vitro and in vivo endothelial cell localization and tracking. J Surg Res. 1996;62:23-28.
39. Askenasy N, Farkas DL. Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells. 2002;20:501-513.
40. Askenasy N, Farkas DL. In vivo imaging studies of the effect of recipient conditioning, donor cell phenotype and antigen disparity on homing of haematopoietic cells to the bone marrow. Br J Haematol. 2003;120:505-515.
41. Sugiyama D, Ogawa M, Hirose I, et al. Erythropoiesis from acetyl LDL incorporating endothelial cells at the preliver stage. Blood. 2003;101:4733-4738.
42. Kihara T, Oshima A, Hirose M, et al. Three-dimensional visualization analysis of in vitro cultured bone fabricated by rat marrow mesenchymal stem cells. Biochem Btophys Res Commun. 2004;316:943-948.
43. Jendelova P, Herynek V, Urdzikova L, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res. 2004;76:232-243.
44. Bai J, Ding W, Yu M, et al. Radionuclide imaging of mesenchymal stem cells transplanted into spinal cord. Neuroreport. 2004;15:1117-1120.
45. Niyibizi C, Wang S, Mi Z, et al. The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells. Mol Ther. 2004;9:955-963.
46. Zhang S, Merritt M, Woessner DE, et al. PARACEST agents: modulating MRI contrast via water proton exchange. Acc Chem Res. 2003;36:783-790.
47. Ferguson B, Wang S, Gray D, et al. Towards functional 3D T-ray imaging. Phys Med Biol. 2002;47:3735-3742.